ID   KCC-TCM902
AC   CVCL_7967
SY   KCC TCM902
DR   Cosmic; 1136966
DR   Cosmic; 1556195
DR   Wikidata; Q54899636
RX   PubMed=18097577;
RX   PubMed=21362583;
RX   PubMed=21631644;
CC   Population: Japanese.
CC   Doubling time: 12.05 hours (PubMed=21362583).
CC   HLA typing: A*11:01 (Direct_author_submission).
CC   Miscellaneous: HLA typing and STR profile from personal communication of Sano D.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 9,10
ST   D18S51: 19
ST   D21S11: 29
ST   D3S1358: 17
ST   D5S818: 10
ST   D7S820: 8,11
ST   D8S1179: 14,16
ST   FGA: 20,24
ST   Penta D: 10,12
ST   Penta E: 10,21
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7965 ! KCC-T873
OI   CVCL_7968 ! KCC-TCM903
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
RX   PubMed=18097577; DOI=10.3892/or.19.1.65;
RA   Taguchi T., Tsukuda M., Imagawa-Ishiguro Y., Kato Y., Sano D.;
RT   "Involvement of EGFR in the response of squamous cell carcinoma of the
RT   head and neck cell lines to gefitinib.";
RL   Oncol. Rep. 19:65-71(2008).
//
RX   PubMed=21362583; DOI=10.1016/j.anl.2011.01.018;
RA   Sakakibara A., Tsukuda M., Kondo N., Ishiguro Y., Kimura M.,
RA   Fujita K., Takahashi H., Matsuda H.;
RT   "Examination of the optimal condition on the in vitro sensitivity to
RT   telomelysin in head and neck cancer cell lines.";
RL   Auris Nasus Larynx 38:589-599(2011).
//
RX   PubMed=21631644; DOI=10.1111/j.1349-7006.2011.01999.x;
RA   Kondo N., Tsukuda M., Taguchi T., Nakazaki K., Sakakibara A.,
RA   Takahashi H., Toth G., Nishimura G.;
RT   "Gene status of head and neck squamous cell carcinoma cell lines and
RT   cetuximab-mediated biological activities.";
RL   Cancer Sci. 102:1717-1723(2011).
//